Nuclear receptor-like transcription factors in fungi.

Members of the metazoan nuclear receptor superfamily regulate gene expression programs in response to binding of cognate lipophilic ligands. Evolutionary studies using bioinformatics tools have concluded that lower eukaryotes, such as fungi, lack nuclear receptor homologs. Here we review recent discoveries suggesting that members of the fungal zinc cluster family of transcription regulators represent functional analogs of metazoan nuclear receptors. These findings indicate that nuclear receptor-like ligand-dependent gene regulatory mechanisms emerged early during eukaryotic evolution, and provide the impetus for further detailed studies of the possible evolutionary and mechanistic relationships of fungal zinc cluster transcription factors and metazoan nuclear receptors. Clinical implications of the discovery of nuclear receptor-like transcription factors in pathogenic fungi will also be discussed.

[1]  E. Dubois,et al.  ArgRII, a Component of the ArgR-Mcm1 Complex Involved in the Control of Arginine Metabolism in Saccharomyces cerevisiae, Is the Sensor of Arginine , 2000, Molecular and Cellular Biology.

[2]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[3]  R. Roeder,et al.  Dynamic regulation of pol II transcription by the mammalian Mediator complex. , 2005, Trends in biochemical sciences.

[4]  R. Tjian,et al.  Transcriptional coactivator complexes. , 2001, Annual review of biochemistry.

[5]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[6]  M. Klepser Antifungal Resistance Among Candida Species , 2001, Pharmacotherapy.

[7]  P. Flynn,et al.  Activation of Transcription by Metabolic Intermediates of the Pyrimidine Biosynthetic Pathway , 1999, Molecular and Cellular Biology.

[8]  B. Turcotte,et al.  A novel DNA binding motif for yeast zinc cluster proteins: the Leu3p and Pdr3p transcriptional activators recognize everted repeats , 1996, Molecular and cellular biology.

[9]  M. Barančík,et al.  P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy. , 2005, Current cancer drug targets.

[10]  D. Peet,et al.  The LXRs: a new class of oxysterol receptors. , 1998, Current opinion in genetics & development.

[11]  Steven Hahn,et al.  Targets of the Gal4 Transcription Activator in Functional Transcription Complexes , 2005, Molecular and Cellular Biology.

[12]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[13]  M Ptashne,et al.  Determinants of binding-site specificity among yeast C6 zinc cluster proteins. , 1993, Science.

[14]  L. Guarente,et al.  Functional dissection and sequence of yeast HAP1 activator , 1989, Cell.

[15]  John S. Satterlee,et al.  An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis , 2006, Nature.

[16]  V. Laudet,et al.  Ligand binding and nuclear receptor evolution , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[17]  P. Schjerling,et al.  Cha4p of Saccharomyces cerevisiae activates transcription via serine/threonine response elements. , 1996, Genetics.

[18]  L. Zhang,et al.  Functional analysis of heme regulatory elements of the transcriptional activator Hap1. , 2000, Biochemical and biophysical research communications.

[19]  M. Downes,et al.  Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. , 1996, Nucleic acids research.

[20]  H. Klocker,et al.  Androgen receptors in prostate cancer. , 2003, Endocrine-related cancer.

[21]  Y. Suzuki,et al.  GAL11 protein, an auxiliary transcription activator for genes encoding galactose-metabolizing enzymes in Saccharomyces cerevisiae , 1988, Molecular and cellular biology.

[22]  S. Mani,et al.  Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer , 2008, Clinical Cancer Research.

[23]  B. Turcotte,et al.  A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins , 2006, Microbiology and Molecular Biology Reviews.

[24]  M. Brandriss,et al.  Isolation of constitutive mutations affecting the proline utilization pathway in Saccharomyces cerevisiae and molecular analysis of the PUT3 transcriptional activator , 1989, Molecular and cellular biology.

[25]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[26]  Millard H. Lambert,et al.  Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors , 2000 .

[27]  G. Kohlhaw Leucine Biosynthesis in Fungi: Entering Metabolism through the Back Door , 2003, Microbiology and Molecular Biology Reviews.

[28]  B. Turcotte,et al.  A Linker Region of the Yeast Zinc Cluster Protein Leu3p Specifies Binding to Everted Repeat DNA* , 1998, The Journal of Biological Chemistry.

[29]  R. Homayouni,et al.  The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans , 2007, PLoS pathogens.

[30]  C. Michels,et al.  Alterations in the Saccharomyces MAL-activator cause constitutivity but can be suppressed by intragenic mutations , 2000, Current Genetics.

[31]  Hanspeter Rottensteiner,et al.  The biochemistry of oleate induction: transcriptional upregulation and peroxisome proliferation. , 2006, Biochimica et biophysica acta.

[32]  A. Goffeau Drug resistance: The fight against fungi , 2008, Nature.

[33]  D. Sanglard,et al.  TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.

[34]  B. Katzenellenbogen,et al.  Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. , 1996, Molecular endocrinology.

[35]  S. Cole,et al.  Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. , 2006, Physiological reviews.

[36]  T. C. White,et al.  Candida albicans UPC2 is transcriptionally induced in response to antifungal drugs and anaerobicity through Upc2p-dependent and -independent mechanisms. , 2008, Microbiology.

[37]  P. Piper,et al.  War1p, a Novel Transcription Factor Controlling Weak Acid Stress Response in Yeast , 2003, Molecular and Cellular Biology.

[38]  W. Moye-Rowley Transcriptional control of multidrug resistance in the yeast Saccharomyces. , 2003, Progress in nucleic acid research and molecular biology.

[39]  C. Michels,et al.  Clustered-charge to alanine scanning mutagenesis of the Mal63 MAL-activator C-terminal regulatory domain , 2003, Current Genetics.

[40]  M. Zupancic,et al.  Nicotinic Acid Limitation Regulates Silencing of Candida Adhesins During UTI , 2005, Science.

[41]  W. Wahli,et al.  PPARs: transcriptional effectors of fatty acids and their derivatives , 2002, Cellular and Molecular Life Sciences CMLS.

[42]  T. Willson,et al.  Pxr, car and drug metabolism , 2002, Nature Reviews Drug Discovery.

[43]  C. Handschin,et al.  Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. , 2005, Archives of biochemistry and biophysics.

[44]  M. Gottesman,et al.  The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research , 2006, FEBS letters.

[45]  R. Savkur,et al.  The coactivator LXXLL nuclear receptor recognition motif. , 2004, The journal of peptide research : official journal of the American Peptide Society.

[46]  Brigitte Meunier,et al.  Transcriptional response to nitrosative stress in Saccharomyces cerevisiae , 2006, Yeast.

[47]  C. Glass,et al.  A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains , 1996, Molecular and cellular biology.

[48]  Peter E Wright,et al.  Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions , 1997, Cell.

[49]  K. Umesono,et al.  Determinants for selective RAR and TR recognition of direct repeat HREs. , 1993, Genes & development.

[50]  R. A. Reid,et al.  Rev-erbα, a Heme Sensor That Coordinates Metabolic and Circadian Pathways , 2007, Science.

[51]  G. Muscat,et al.  The orphan Rev-erb nuclear receptors: a link between metabolism, circadian rhythm and inflammation? , 2006, Nuclear receptor signaling.

[52]  P. Sassone-Corsi,et al.  Circadian rhythms: Metabolic clockwork , 2007, Nature.

[53]  R. O. Poyton,et al.  Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. , 2006, Cell metabolism.

[54]  J. Sobel,et al.  Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison toC. albicans , 1999, Clinical Microbiology Reviews.

[55]  A. Goffeau,et al.  The pleitropic drug ABC transporters from Saccharomyces cerevisiae. , 2001, Journal of molecular microbiology and biotechnology.

[56]  Timothy M Willson,et al.  The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. , 2002, Endocrine reviews.

[57]  B. Luisi,et al.  On the mechanism of DNA binding by nuclear hormone receptors: A structural and functional perspective , 1993, Journal of cellular biochemistry.

[58]  M. Lazar,et al.  The N-CoR/Histone Deacetylase 3 Complex Is Required for Repression by Thyroid Hormone Receptor , 2003, Molecular and Cellular Biology.

[59]  Fajun Yang,et al.  Mediator Subunit Gal11p/MED15 Is Required for Fatty Acid-dependent Gene Activation by Yeast Transcription Factor Oaf1p* , 2009, Journal of Biological Chemistry.

[60]  L. Piddock Multidrug-resistance efflux pumps ? not just for resistance , 2006, Nature Reviews Microbiology.

[61]  Chen Gao,et al.  On the Mechanism of Constitutive Pdr1 Activator-mediated PDR5 Transcription in Saccharomyces cerevisiae , 2004, Journal of Biological Chemistry.

[62]  E. Dubois,et al.  The proper folding of a long C‐terminal segment of the yeast Lys14p regulator is required for activation of LYS genes in response to the metabolic effector , 2002, Molecular microbiology.

[63]  H. Gronemeyer,et al.  The nuclear receptor ligand-binding domain: structure and function. , 1998, Current opinion in cell biology.

[64]  Li Zhang,et al.  Structural Environment Dictates the Biological Significance of Heme-Responsive Motifs and the Role of Hsp90 in the Activation of the Heme Activator Protein Hap1 , 2003, Molecular and Cellular Biology.

[65]  M. Zupancic,et al.  A yeast by any other name: Candida glabrata and its interaction with the host. , 2005, Current opinion in microbiology.

[66]  Fred Winston,et al.  Heme Levels Switch the Function of Hap1 of Saccharomyces cerevisiae between Transcriptional Activator and Transcriptional Repressor , 2007, Molecular and Cellular Biology.

[67]  K. Struhl,et al.  A nuclear receptor-like pathway regulating multidrug resistance in fungi , 2008, Nature.

[68]  S. Ekins,et al.  Evolution of pharmacologic specificity in the pregnane X receptor , 2008, BMC Evolutionary Biology.

[69]  J. Schwabe,et al.  Beyond zinc fingers: steroid hormone receptors have a novel structural motif for DNA recognition. , 1991, Trends in biochemical sciences.

[70]  R. Homayouni,et al.  Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies , 2006, Molecular microbiology.

[71]  L. Guarente,et al.  Heme binds to a short sequence that serves a regulatory function in diverse proteins. , 1995, The EMBO journal.

[72]  V. Jordan,et al.  Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs). , 2005, Breast disease.

[73]  B. Luisi,et al.  The steroid/nuclear receptors: from three-dimensional structure to complex function. , 1994, Vitamins and hormones.

[74]  C. Jacq,et al.  PDR3, a new yeast regulatory gene, is homologous toPDR1 and controls the multidrug resistance phenomenon , 1994, Molecular and General Genetics MGG.

[75]  Steven M. Lipkin,et al.  The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors , 1991, Cell.

[76]  F. Claessens,et al.  The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1 , 1999, Molecular and Cellular Biology.

[77]  M. Brandriss Evidence for positive regulation of the proline utilization pathway in Saccharomyces cerevisiae. , 1987, Genetics.

[78]  A. Goffeau,et al.  Yeast multidrug resistance: The PDR network , 1995, Journal of bioenergetics and biomembranes.

[79]  D. Edwards,et al.  The Steroid Receptor Coactivator-1 Contains Multiple Receptor Interacting and Activation Domains That Cooperatively Enhance the Activation Function 1 (AF1) and AF2 Domains of Steroid Receptors* , 1998, The Journal of Biological Chemistry.

[80]  A. Gibson,et al.  Functional domain analysis of the Saccharomyces MAL-activator , 1999, Current Genetics.

[81]  K. Yamamoto,et al.  A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans. , 2006, Genes & development.

[82]  A. De Las Peñas,et al.  Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing. , 2003, Genes & development.

[83]  D. Montell,et al.  Regulation of Invasive Cell Behavior by Taiman, a Drosophila Protein Related to AIB1, a Steroid Receptor Coactivator Amplified in Breast Cancer , 2000, Cell.

[84]  K. Kuchler,et al.  Weak Organic Acids Trigger Conformational Changes of the Yeast Transcription Factor War1 in Vivo to Elicit Stress Adaptation* , 2008, Journal of Biological Chemistry.

[85]  Karl Kuchler,et al.  Expression regulation of the yeast PDR5 ATP‐binding cassette (ABC) transporter suggests a role in cellular detoxification during the exponential growth phase , 2004, FEBS letters.

[86]  M. Brandriss,et al.  Proline-independent binding of PUT3 transcriptional activator protein detected by footprinting in vivo , 1991, Molecular and cellular biology.

[87]  S. Khorasanizadeh,et al.  Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ , 2007, Nature Structural &Molecular Biology.

[88]  R. J. Reece,et al.  Modulation of transcription factor function by an amino acid: activation of Put3p by proline , 2003, The EMBO journal.

[89]  N. Bot,et al.  Fungi and animals may share a common ancestor to nuclear receptors. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[90]  V. Laudet,et al.  Bioinformatics of nuclear receptors. , 2003, Methods in enzymology.

[91]  T. C. White,et al.  cis-Acting Elements within the Candida albicans ERG11 Promoter Mediate the Azole Response through Transcription Factor Upc2p , 2007, Eukaryotic Cell.

[92]  D. Waxman,et al.  Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR) , 2006, Drug metabolism reviews.

[93]  A. Andrianopoulos,et al.  Evolution of a fungal regulatory gene family: the Zn(II)2Cys6 binuclear cluster DNA binding motif. , 1997, Fungal genetics and biology : FG & B.

[94]  B. Turcotte,et al.  Zinc Cluster Proteins Leu3p and Uga3p Recognize Highly Related but Distinct DNA Targets* , 1998, The Journal of Biological Chemistry.

[95]  R. Roeder,et al.  Role of general and gene-specific cofactors in the regulation of eukaryotic transcription. , 1998, Cold Spring Harbor symposia on quantitative biology.

[96]  Li Zhang,et al.  The Heme Activator Protein Hap1 Represses Transcription by a Heme-Independent Mechanism in Saccharomyces cerevisiae , 2005, Genetics.

[97]  H. Krause,et al.  The Drosophila Nuclear Receptor E75 Contains Heme and Is Gas Responsive , 2005, Cell.

[98]  A. Goffeau,et al.  Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes , 1997, Molecular and General Genetics MGG.

[99]  Nutrient-regulated gene expression in eukaryotes. , 2006, Biochemical Society symposium.

[100]  A large internal deletion converts yeast LEU3 to a constitutive transcriptional activator. , 1989, Molecular and cellular biology.

[101]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[102]  S. Tenreiro,et al.  Adaptive response to the antimalarial drug artesunate in yeast involves Pdr1p/Pdr3p-mediated transcriptional activation of the resistance determinants TPO1 and PDR5. , 2006, FEMS yeast research.

[103]  M. Teboul,et al.  Fatty acid activation of peroxisome proliferator-activated receptor (PPAR) , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[104]  D. Nie,et al.  Human pregnane X receptor and resistance to chemotherapy in prostate cancer. , 2007, Cancer research.

[105]  V. Laudet,et al.  Evolutionary genomics of nuclear receptors: from twenty-five ancestral genes to derived endocrine systems. , 2004, Molecular biology and evolution.

[106]  E. Mylonakis,et al.  Developments in the treatment of candidiasis: more choices and new challenges , 2006, Expert opinion on investigational drugs.

[107]  V. Laudet,et al.  The evolution of the nuclear receptor superfamily. , 2004, Essays in biochemistry.

[108]  S. B. Cooper,et al.  The Mediator Subunit MDT-15 Confers Metabolic Adaptation to Ingested Material , 2008, PLoS genetics.

[109]  J. Bennett,et al.  Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants , 2006, Antimicrobial Agents and Chemotherapy.

[110]  W. Wahli,et al.  Transcriptional regulation of metabolism. , 2006, Physiological reviews.

[111]  C. Glass,et al.  Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. , 1993, Genes & development.

[112]  N. Lehming,et al.  Why Ppr1p is a weak activator of transcription , 2001, FEBS letters.

[113]  T. Willson,et al.  Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes , 2001, Genome Biology.

[114]  M. Downes,et al.  Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains. , 2000, Molecular endocrinology.

[115]  R. J. Reece Molecular basis of nutrient-controlled gene expression in Saccharomyces cerevisiae , 2000, Cellular and Molecular Life Sciences CMLS.

[116]  P. Schjerling,et al.  Comparative amino acid sequence analysis of the C6 zinc cluster family of transcriptional regulators. , 1996, Nucleic acids research.

[117]  C. J. Jeong,et al.  Evidence that Gal11 protein is a target of the Gal4 activation domain in the mediator. , 2001, Biochemistry.

[118]  N. Mitro,et al.  The nuclear receptor LXR is a glucose sensor , 2007, Nature.

[119]  A. Goffeau,et al.  The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. , 1987, The Journal of biological chemistry.

[120]  R. J. Reece,et al.  Eukaryotic transcription factors as direct nutrient sensors. , 2005, Trends in biochemical sciences.

[121]  W. S. Moye-Rowley,et al.  Transcriptional control of the yeast PDR5 gene by the PDR3 gene product , 1994, Molecular and cellular biology.

[122]  A. Zelent,et al.  Origins and evolutionary diversification of the nuclear receptor superfamily , 2000, Cellular and Molecular Life Sciences CMLS.

[123]  Mehdi Mollapour,et al.  Moderately lipophilic carboxylate compounds are the selective inducers of the Saccharomyces cerevisiae Pdr12p ATP‐binding cassette transporter , 2003, Yeast.

[124]  F. Devaux,et al.  Early Expression of Yeast Genes Affected by Chemical Stress , 2005, Molecular and Cellular Biology.

[125]  T. Edlind,et al.  Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor , 2004, Antimicrobial Agents and Chemotherapy.

[126]  J. Lee,et al.  The Conformation of the Glucocorticoid Receptor AF1/tau1 Domain Induced by Osmolyte Binds Co-regulatory Proteins* , 2001, The Journal of Biological Chemistry.

[127]  T. Willson,et al.  Peroxisome proliferator-activated receptors: from genes to physiology. , 2001, Recent progress in hormone research.

[128]  L. Guarente,et al.  Organization of the regulatory region of the yeast CYC7 gene: multiple factors are involved in regulation , 1987, Molecular and cellular biology.

[129]  Jasper Rine,et al.  Upc2p and Ecm22p, Dual Regulators of Sterol Biosynthesis in Saccharomyces cerevisiae , 2001, Molecular and Cellular Biology.

[130]  F. Robert,et al.  Genomewide Location Analysis of Candida albicans Upc2p, a Regulator of Sterol Metabolism and Azole Drug Resistance , 2008, Eukaryotic Cell.

[131]  J. Lehmann,et al.  Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. , 2000, Molecular cell.

[132]  L. Moore,et al.  The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.

[133]  B. André,et al.  Transcriptional Induction by Aromatic Amino Acids in Saccharomyces cerevisiae , 1999, Molecular and Cellular Biology.

[134]  M. Klepser Candida Resistance and Its Clinical Relevance , 2006, Pharmacotherapy.

[135]  B. Dujon,et al.  Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata , 2004, Molecular microbiology.

[136]  A. Traven,et al.  Yeast Gal4: a transcriptional paradigm revisited , 2006, EMBO reports.

[137]  L. Zhang,et al.  Molecular mechanism of heme signaling in yeast: the transcriptional activator Hap1 serves as the key mediator , 1999, Cellular and Molecular Life Sciences CMLS.

[138]  C. Glass,et al.  Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. , 2006, Genes & development.

[139]  R. Homayouni,et al.  A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate , 2008, Eukaryotic Cell.

[140]  T. Giordano,et al.  Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines , 2007, Cancer.

[141]  Kendall W Nettles,et al.  Ligand control of coregulator recruitment to nuclear receptors. , 2005, Annual review of physiology.

[142]  M. Johnston,et al.  Rgt1p of Saccharomyces cerevisiae, a key regulator of glucose-induced genes, is both an activator and a repressor of transcription , 1996, Molecular and cellular biology.

[143]  V. Laudet,et al.  The nuclear receptor superfamily , 2003, Journal of Cell Science.

[144]  K. Umesono,et al.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.

[145]  T. Burris Nuclear hormone receptors for heme: REV-ERBalpha and REV-ERBbeta are ligand-regulated components of the mammalian clock. , 2008, Molecular endocrinology.

[146]  L. W. Parks,et al.  Transcriptional regulation by ergosterol in the yeast Saccharomyces cerevisiae , 1996, Molecular and cellular biology.

[147]  C. Glass,et al.  Coregulator Codes of Transcriptional Regulation by Nuclear Receptors* , 2001, The Journal of Biological Chemistry.

[148]  K. Kuchler,et al.  Fungal ATP-binding cassette (ABC) transporters in drug resistance & detoxification. , 2006, Current drug targets.